Hui R. Cui

Suite 901, Changtai Plaza, 2889 Jinke Road
Pudong, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Design, Synthesis and Biological Evaluation of Novel, Potent, Selective and Orally Available DGKα Inhibitors for the Treatment of Tumors.

Design, Synthesis and Biological Evaluation of Novel, Potent, Selective and Orally Available DGKα Inhibitors for the Treatment of Tumors.

Journal: Journal of medicinal chemistry

Published: December 01, 2025

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.

Journal: Nature biotechnology

Published: November 17, 2025

Discovery of Novel, Potent, Selective, and Orally Available DGKα Inhibitors for the Treatment of Tumors.

Discovery of Novel, Potent, Selective, and Orally Available DGKα Inhibitors for the Treatment of Tumors.

Journal: Journal of medicinal chemistry

Published: September 08, 2025

Rational Design and Identification of ISM7594 as a Tissue-Agnostic FGFR2/3 Inhibitor.

Rational Design and Identification of ISM7594 as a Tissue-Agnostic FGFR2/3 Inhibitor.

Journal: Journal of medicinal chemistry

Published: June 25, 2025

Design, Synthesis, and Biological Evaluation of Novel Orally Available Covalent CDK12/13 Dual Inhibitors for the Treatment of Tumors.

Design, Synthesis, and Biological Evaluation of Novel Orally Available Covalent CDK12/13 Dual Inhibitors for the Treatment of Tumors.

Journal: Journal of medicinal chemistry

Published: February 14, 2025

A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial.

A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial.

Journal: Nature medicine

Published: December 19, 2024

Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors.

Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors.

Journal: Nature communications

Published: August 28, 2024

Associations between cytokine levels and cognitive function among individuals at clinical high risk for psychosis.

Associations between cytokine levels and cognitive function among individuals at clinical high risk for psychosis.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: April 22, 2024

Complete genome sequences and comparative secretomic analysis for the industrially cultivated edible mushroom Lyophyllum decastes reveals insights on evolution and lignocellulose degradation potential.

Complete genome sequences and comparative secretomic analysis for the industrially cultivated edible mushroom Lyophyllum decastes reveals insights on evolution and lignocellulose degradation potential.

Journal: Frontiers in microbiology

Published: January 04, 2023

Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference.

Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference.

Journal: iScience

Published: June 03, 2022

Graph Triple-Attention Network for Disease-Related LncRNA Prediction.

Graph Triple-Attention Network for Disease-Related LncRNA Prediction.

Journal: IEEE journal of biomedical and health informatics

Published: November 23, 2021

Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling.

Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: October 25, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026